to surgery, is controversial4" and may merit reappraisal.The disease has a dismal prognosis, with an average survival of 13 4 months after treat- ment, and a five year survival of 4 2o%.'When metastases are present, survival averages only one to five months.
No takes yet. Share an insight, caveat, or question.
Denton et al. (1990) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: